Ubs Group Ag Bio Restorative Therapies, Inc. Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 27,813 shares of BRTX stock, worth $47,838. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,813
Previous 840
3211.07%
Holding current value
$47,838
Previous $1,000
5500.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BRTX
# of Institutions
14Shares Held
249KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA52.3KShares$90,0190.0% of portfolio
-
Stone X Group Inc.50.1KShares$86,1720.01% of portfolio
-
Wealth Alliance Mellville, NY40KShares$68,8000.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.5KShares$35,2110.0% of portfolio
-
State Street Corp Boston, MA20.5KShares$35,1890.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $6.28M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...